Source: Horizon Pharma Plc (HZNP.O) said it would buy Raptor Pharmaceutical Corp (RPTP.O) for nearly $800 million to bolster its portfolio of drugs to treat rare diseases and reduce its dependence on the primary care market. The deal will give Horizon drugs used to treat diseases including rare metabolic disorders…...